Serum Metabolome Alterations in Patients with Nonalcoholic Fatty Liver Disease

Supplementary Data S1: In the negative mode the raw data of metabolites of all participants (149NAFLD and 149HCs).
Supplementary Data S2: In the positive mode the raw data of metabolites of all participants (149NAFLD and 149HCs).
Supplementary Data S3: Metabolites detected(100NAFLD and 100HCs) in the negative mode in the training set.
Supplementary Data S4: Metabolites detected in the positive mode in the training set(100NAFLD and 100HCs).
Supplementary Data S5: Differential metabolites between NAFLDs and healthy controls in discovery set.
Supplementary Data S6: Differential metabolites between NAFLDs and healthy controls in validation set.
Supplementary Data S7: Calculated data for volcanic maps.
Supplementary Data S8: Metabolite classification analysis.
Supplementary Data S9：metabolites correlation coefficient.
Supplementary Data S10：p-value of metabolites.
Supplementary Data S11：Brite A of KEGG brite Database.
Supplementary Data S12：Brite B of KEGG brite Database.
Supplementary Data S13：Brite C of KEGG brite Database.
Supplementary Data S14：KEGG metabolic pathway information sheet.
Supplementary Data S15：Results of differential metabolite KEGG enrichment analysis.
Supplementary Data S16：Results of KEGG pathway topological analysis of the differential metabolites.
Supplementary Data S17：32 serum metabolite markers
Supplementary Data S18：p-value of Spearman correlation analysis.
Supplementary Data S19：rho-value of Spearman correlation analysis.